Literature DB >> 7615819

Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.

N K Rao1, G P Shi, H A Chapman.   

Abstract

Binding of urokinase to the glycolipid-anchored urokinase receptor (uPAR) has been implicated in macrophage differentiation. However, no biochemical markers of differentiation have yet been directly linked to uPAR occupancy. As extensive changes in proteolytic profile characterize monocytic differentiation, we have examined the role of uPAR occupancy on protease expression by differentiating phagocytes. Antibodies to either urokinase or to uPAR that prevent receptor binding inhibited induction of cathepsin B in cultured monocytes and both cathepsin B and 92-kD gelatinase mRNA and protein in phorbol diester-stimulated myeloid cells. Mannosamine, an inhibitor of glycolipid anchor assembly, also blocked protease expression. Anti-catalytic urokinase antibodies, excess inactive urokinase, or aprotinin had no effect, indicating that receptor occupancy per se regulated protease expression. Antibodies to the integrins CD11a and CD29 or to the glycolipid-anchored proteins CD14 and CD55 also had no effect. Protease induction was independent of matrix attachment. Antibodies to urokinase or uPAR affected neither the decrease in cathepsin G nor the increase in tumor necrosis factor-alpha in phorbol ester-stimulated cells. These data establish that uPAR is a multifunctional receptor, not only promoting pericellular proteolysis and matrix attachment, but also effecting cysteine- and metallo-protease expression during macrophage differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615819      PMCID: PMC185220          DOI: 10.1172/JCI118057

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.

Authors:  D A Waltz; H A Chapman
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

2.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

Authors:  H G Welgus; E J Campbell; J D Cury; A Z Eisen; R M Senior; S M Wilhelm; G I Goldberg
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

3.  Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.

Authors:  H A Chapman; P Bertozzi; L Z Sailor; A R Nusrat
Journal:  Am J Physiol       Date:  1990-12

4.  Urokinase receptors in human monocytes.

Authors:  A Nykjaer; C M Petersen; E I Christensen; O Davidsen; J Gliemann
Journal:  Biochim Biophys Acta       Date:  1990-05-22

5.  Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding.

Authors:  H P Hohmann; R Remy; B Pöschl; A P van Loon
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

6.  "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin.

Authors:  N Guinec; V Dalet-Fumeron; M Pagano
Journal:  Biol Chem Hoppe Seyler       Date:  1993-12

7.  The urokinase receptor is required for human monocyte chemotaxis in vitro.

Authors:  M R Gyetko; R F Todd; C C Wilkinson; R G Sitrin
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

8.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

9.  Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.

Authors:  O Wilhelm; U Weidle; S Höhl; P Rettenberger; M Schmitt; H Graeff
Journal:  FEBS Lett       Date:  1994-01-10       Impact factor: 4.124

10.  Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukaemia cell line.

Authors:  D Burnett; J Crocker; A T Vaughan
Journal:  J Cell Physiol       Date:  1983-06       Impact factor: 6.384

View more
  20 in total

1.  Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

Authors:  Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

2.  Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.

Authors:  G Cirino; C Cicala; M Bucci; L Sorrentino; G Ambrosini; G DeDominicis; D C Altieri
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

3.  uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.

Authors:  Reshu Gupta; Arun Kumar Nalla; Venkateswara Rao Gogineni; Chandramu Chetty; Praveen Bhoopathi; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

4.  Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

5.  Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Authors:  Z Szekanecz; G K Haines; A E Koch
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

7.  Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

Authors:  M E Kroon; P Koolwijk; H van Goor; U H Weidle; A Collen; G van der Pluijm; V W van Hinsbergh
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

8.  MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.

Authors:  Krishna Kumar Veeravalli; Chandramu Chetty; Shivani Ponnala; Christopher S Gondi; Sajani S Lakka; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

9.  Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.

Authors:  Mark W Gramling; Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2009-11-03       Impact factor: 3.905

10.  RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.

Authors:  Sateesh Kunigal; Sajani S Lakka; Christopher S Gondi; Norman Estes; Jasti S Rao
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.